封面
市場調查報告書
商品編碼
1460146

腦電圖系統市場 - 按產品、類型、應用、最終用途 - 全球預測,2024 年 - 2032 年

Electroencephalograph Systems Market - By Product, Type, Application, End-use - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 201 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在神經系統疾病盛行率上升和技術不斷進步的推動下,腦電圖系統市場預計在 2024 年至 2032 年間以 6.4% 的CAGR成長。隨著越來越多的人受到癲癇、阿茲海默症和帕金森氏症等疾病的影響,對腦電圖 (EEG) 系統等準確診斷工具的需求不斷增加。無線連接、可攜式設備和先進的訊號處理演算法等技術創新有助於提高腦電圖系統的效率和精確度,使其在神經系統疾病的診斷和監測中不可或缺。

2024 年 2 月,Neurotechnology 升級了 BrainAccess 套件,提供完整的乾接觸腦電圖解決方案,包括頭飾、電極、腦電圖儀、腦電圖資料收集和視覺化軟體,以及用於設定腦電圖實驗的通用基礎設施。尖端技術的不斷發展和產品接受度的不斷提高將促進市場成長。

腦電圖系統產業分為產品、類型、應用、最終用途和區域。

根據產品,多通道細分市場的市場規模預計在 2024 年至 2032 年間將以 6.6% 的CAGR成長。多通道腦電圖系統提供增強的能力,以更高的精度和細節監測大腦活動,以滿足不同的臨床和研究需求。這些系統能夠同時記錄多個大腦區域,從而提供對神經系統疾病、睡眠模式和認知功能的全面見解。神經系統疾病的盛行率不斷上升,加上神經科學研究活動的不斷增加,推動了對先進多通道腦電圖系統的需求。此外,提供即時資料分析、可自訂電極配置和動態監測位置的攜帶性的強大能力將進一步促進該細分市場的成長。

在應用方面,預計到 2032 年,睡眠障礙領域的腦電圖系統市場CAGR將達到6.3%。腦電圖系統已成為診斷和監測睡眠障礙(如失眠、睡眠呼吸中止症和異態睡眠)的重要解決方案。它們也為不同睡眠階段的睡眠模式、腦電波活動和異常提供了寶貴的見解。由於生活方式的改變和人口老化,全球睡眠障礙盛行率不斷上升,對先進腦電圖技術的需求可能會大幅激增。

鑑於區域格局,在醫療保健支出增加、對神經系統疾病的認知不斷提高以及研發活動不斷擴大的推動下,亞太地區腦電圖系統產業將在 2024 年至 2032 年間呈現強勁成長。由於神經系統疾病、睡眠相關疾病的日益普及以及對準確診斷工具的需求,中國、印度、日本和韓國對腦電圖系統的需求激增。例如,2023 年 8 月,楊潞齡醫學院、睡眠與認知中心的研究人員與 Oura Health 合作發現,亞洲人的睡眠品質比歐洲和北美人的睡眠品質更差。醫療基礎設施的強勁進步、老年人口的增加以及政府舉措將進一步增強該地區的行業前景。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 神經系統疾病的發生率不斷上升
      • 神經科學研究的增加
      • 技術進步與產品創新
      • 意識和醫療基礎設施不斷提高
    • 產業陷阱與挑戰
      • 腦電圖設備成本高
      • 解釋和標準化方面的挑戰
  • 成長潛力分析
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 8通道腦電圖
  • 21通道腦電圖
  • 25通道腦電圖
  • 32通道腦電圖
  • 40通道腦電圖
  • 多通道腦電圖

第 6 章:市場估計與預測:按類型,2018 - 2032

  • 主要趨勢
  • 攜帶式設備
  • 獨立設備

第 7 章:市場估計與預測:按應用分類,2018 年 - 2032 年

  • 主要趨勢
  • 癲癇
  • 睡眠障礙
  • 腦腫瘤和病變
  • 中風
  • 精神疾病
  • 腦圖譜
  • 其他應用

第 8 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 神經病學中心
  • 診斷中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Bio-Logic Systems Corporation
  • BrainScope Company, Inc.
  • Cadwell Industries, Inc.
  • Compumedic Neuroscan
  • Compumedics Limited
  • EBNeuro S.p.A.
  • Elekta AB
  • Interaxon Inc.
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroWave Systems Inc.
簡介目錄
Product Code: 3927

Electroencephalograph Systems Market is poised to expand at 6.4% CAGR between 2024 and 2032 driven by the rising prevalence of neurological disorders and the continuous technological advancements. With an increasing number of individuals affected by conditions, such as epilepsy, Alzheimer's, and Parkinson's diseases, there is a heightened demand for accurate diagnostic tools like electroencephalograph (EEG) systems. Technological innovations, such as wireless connectivity, portable devices, and advanced signal processing algorithms help enhance the efficiency and precision of EEG systems, making them indispensable in the diagnosis and monitoring of neurological conditions.

In February 2024, Neurotechnology upgraded its BrainAccess kits to provide a complete dry-contact electroencephalography solution comprising headwear, electrodes, an electroencephalograph, and software for EEG data collection and visualization, along with general infrastructure for setting up EEG experiments. This rising development of cutting-edge technologies and the product surging acceptance will add to the market growth.

The EEG systems industry is segmented into product, type, application, end-use, and region.

Based on product, the market size from the multi-channel segment is projected to accrue 6.6% CAGR between 2024 and 2032. Multi-channel EEG systems offer enhanced capabilities in monitoring brain activity with higher precision and detail for catering to diverse clinical and research needs. These systems enable simultaneous recording from multiple brain regions for providing comprehensive insights into neurological disorders, sleep patterns, and cognitive functions. The rising prevalence of neurological diseases, coupled with increasing research activities in neuroscience is fueling the demand for advanced multi-channel EEG systems. Additionally, the strong ability to offer real-time data analysis, customizable electrode configurations, and portability for ambulatory monitoring positions will further contribute to the segment growth.

In terms of application, the electroencephalograph systems market from the sleep disorders segment is anticipated to witness 6.3% CAGR through 2032. EEG systems have emerged as essential solutions for diagnosing and monitoring sleep disorders, such as insomnia, sleep apnea, and parasomnias. They also provide invaluable insights into sleep patterns, brain wave activities, and abnormalities during different sleep stages. With the rising global prevalence of sleep disorders due to lifestyle changes and aging populations, the demand for advanced EEG technologies is likely to significantly surge.

Given the regional landscape, the Asia Pacific electroencephalograph systems industry is set to exhibit robust growth between 2024 and 2032 fueled by the increasing healthcare expenditure, rising awareness about neurological disorders, and expanding R&D activities. China, India, Japan, and South Korea are witnessing a surge in demand for EEG systems due to the growing prevalence of neurological conditions, sleep-related disorders, and the need for accurate diagnostic tools. For instance, in August 2023, researchers from the Yong Loo Lin School of Medicine along with the Centre for Sleep and Cognition in collaboration with Oura Health, discovered that Asians report worse sleep than people living in Europe and North America. Strong advancements in healthcare infrastructure, the rising geriatric population, and government initiatives will further augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing incidence of neurological disorders
      • 3.2.1.2 Increased research in neuroscience
      • 3.2.1.3 Technological advancements and product innovations
      • 3.2.1.4 Rising awareness and healthcare infrastructure
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of EEG equipment
      • 3.2.2.2 Challenges in interpretation and standardization
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 8-channel EEG
  • 5.3 21-channel EEG
  • 5.4 25-channel EEG
  • 5.5 32-channel EEG
  • 5.6 40-channel EEG
  • 5.7 Multi-channel EEG

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Portable device
  • 6.3 Standalone device

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Epilepsy
  • 7.3 Sleep disorders
  • 7.4 Brain tumours and lesions
  • 7.5 Stroke
  • 7.6 Psychiatric disorders
  • 7.7 Brain mapping
  • 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Neurology centers
  • 8.4 Diagnostic centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Bio-Logic Systems Corporation
  • 10.2 BrainScope Company, Inc.
  • 10.3 Cadwell Industries, Inc.
  • 10.4 Compumedic Neuroscan
  • 10.5 Compumedics Limited
  • 10.6 EBNeuro S.p.A.
  • 10.7 Elekta AB
  • 10.8 Interaxon Inc.
  • 10.9 Medtronic plc
  • 10.10 Natus Medical Incorporated
  • 10.11 NeuroWave Systems Inc.